Other Cancer
Showing 1 - 25 of >10,000
Monitoring T Cell Responses in Melanoma, Lung and Other Cancer
Recruiting
- Clinical Stage III Cutaneous Melanoma AJCC v8
- +9 more
- Biospecimen Collection
- Electronic Health Record Review
-
Rochester, MinnesotaMayo Clinic in Rochester
Oct 4, 2023
Breast Cancer, Oligoprogressive, Head Neck Cancer Trial in Sacramento (Ablative local therapy)
Recruiting
- Breast Cancer
- +4 more
- Ablative local therapy
-
Sacramento, CaliforniaUniversity of California, Davis
Oct 19, 2023
Intrinsic Radiation Sensitivity in Cancer Patients
Recruiting
- Nasopharyngeal Cancer
- +2 more
-
Singapore, SingaporeNational Cancer Center Singapore
Dec 1, 2022
Eribulin-Based Regimen Versus Other Chemotherpy in
Active, not recruiting
- Breast Cancer
- Eribulin-Based Regimen
- +2 more
-
Fuzhou, Fujian, ChinaFujian Cancer Hospital
Jul 18, 2023
Pancreatic Cancer Trial in United States (MVT-5873, modified FOLFIRINOX (mFOLFIRINOX))
Recruiting
- Pancreatic Cancer
- MVT-5873
- modified FOLFIRINOX (mFOLFIRINOX)
-
Scottsdale, Arizona
- +3 more
Aug 17, 2022
Other Cancer Trial in Boston (Mobile App + enhanced standard care, Enhanced Standard Care)
Active, not recruiting
- Other Cancer
- Mobile App + enhanced standard care
- Enhanced Standard Care
-
Boston, MassachusettsMassachusetts General Hospital Cancer Center
Jan 24, 2023
Atrial Fibrillation and Other Cardiac Arrhythmias and Diseases
Not yet recruiting
- Breast Cancer
- +4 more
- Screening for atrial fibrillation and other cardiac arrhythmias and diseases
-
Toulouse, FranceClinique Pasteur
Oct 9, 2023
Li-Fraumeni Syndrome Trial in Boston, New York (Whole Body MRI)
Recruiting
- Li-Fraumeni Syndrome
- Whole Body MRI
-
Boston, Massachusetts
- +1 more
Jan 14, 2022
Other Cancer Trial in Boston (PediCARE, Usual Care)
Completed
- Other Cancer
- PediCARE
- Usual Care
-
Boston, MassachusettsDana Farber Cancer Institute
May 6, 2022
Colorectal Cancer, Solid Tumors Trial (SNDX-5613, Chemotherapy)
Not yet recruiting
- Colorectal Cancer
- Solid Tumors
- (no location specified)
Feb 15, 2023
Cervical Cancer Trial in Worldwide (tisotumab vedotin, topotecan, vinorelbine)
Recruiting
- Cervical Cancer
- tisotumab vedotin
- +5 more
-
Birmingham, Alabama
- +138 more
Aug 15, 2022
Lung Cancer, Liver Cancer, Breast Cancer Trial in Halifax (CBCT Imaging)
Not yet recruiting
- Lung Cancer
- +3 more
- CBCT Imaging
-
Halifax, Nova Scotia, CanadaNova Scotia Health (QEII)
Aug 3, 2022
HER2+ Advanced Breast Cancer, Other Solid Tumors Trial (ADCC-R-Epo-R T-cells + Trastuzumab, Erythropoietin beta, Fludarabine and
Not yet recruiting
- HER2+ Advanced Breast Cancer
- Other Solid Tumors
- ADCC-R-Epo-R T-cells + Trastuzumab
- +2 more
- (no location specified)
Aug 31, 2023
HER2-positive Breast Cancer, Advanced Breast Cancer Trial in Phoenix, Miami, Boston (Prolonged Overnight Fasting,
Not yet recruiting
- HER2-positive Breast Cancer
- Advanced Breast Cancer
- Prolonged Overnight Fasting
- +2 more
-
Phoenix, Arizona
- +2 more
Nov 8, 2023
Cancer in Patients on Dapagliflozin and Other Antidiabetic
Recruiting
- Breast Cancer
- Bladder Cancer
-
Wilmington, Delaware
- +3 more
Jan 13, 2023
Oesophageal Adenocarcinoma, Squamous Cell Carcinoma, Solid Tumor Trial in United Kingdom (M6620, Cisplatin, Capecitabine)
Completed
- Oesophageal Adenocarcinoma
- +2 more
- M6620
- +3 more
-
Cardiff, United Kingdom
- +4 more
Apr 27, 2022
Other Cancer Trial in Boston (Usual Care, Geriatric Oncology Collaborative Care)
Completed
- Other Cancer
- Usual Care
- Geriatric Oncology Collaborative Care
-
Boston, MassachusettsMassachusetts General Hospital Cancer Center
Apr 6, 2022
Advanced Solid Tumor, Advanced Breast Cancer, Metastatic Breast Cancer Trial (BGB-43395, Fulvestrant, Letrozole)
Not yet recruiting
- Advanced Solid Tumor
- +8 more
- BGB-43395
- +2 more
- (no location specified)
Nov 13, 2023